期刊文献+

噬血细胞综合征患儿的临床诊断与骨髓细胞学特点分析 被引量:3

Analysis of clinical diagnosis and bone-marrow cytological characteristics of childhood hemophagocytic syndrome
下载PDF
导出
摘要 目的探讨儿童噬血细胞综合征的临床诊断标准及其骨髓细胞学检查结果对于临床诊断的意义。方法回顾分析2008年5月-2011年5月于我院确诊为噬血细胞综合征的22例患儿的病历资料及骨髓细胞学特点。结果 22例患儿均符合国际组织细胞协会HLH-2004方案诊断标准。均有发热、脾大及血清铁蛋白增高,18/22例(82%)伴外周血至少两系减低,15/19例(79%)伴低纤维蛋白原血症,14/20例(70%)伴高三酰甘油血症,14/22例(64%)患儿在初诊时骨髓中找到噬血细胞。结论骨髓涂片见到噬血细胞不是儿童噬血细胞综合征临床诊断的必备条件,初诊时进行骨髓细胞学检查有助于噬血细胞综合征的诊断与鉴别诊断,在治疗过程中复查骨髓有助于指导治疗。 Objective To discuss the clinical diagnostic standard of childhood hemophagocytic syndrome (HPS) and investigate the significance of bone-marrow cytological results to the clinical diagnosis. Methods A total of 22 children with HPS in Tianjin Children's Hospital from May 2008 to May 2011 were enrolled in this study. The bone-marrow cytological features obtained in their initial diagnosis, and their clinical data were analyzed retrospectively. HLH-2004 is adopted as the diagnosis standard. Results All patients were presented with fever, splenomegaly and high-level ferritin; they were in line with the diagnosis standard of HLH-2004. Among them, 81.8% of patients (18/22) were combined with peripheral cytopenia in more than two lineages; 78.9% of patients (15/19) had hypofibrinogenemia; 70% of hypertriglyceridemia and 63.6% had hemophagocytosis. Conclusions Hemophagoc patients (14/20) had ytosis of bone marrow is not necessary in the clinical diagnosis of HPS based on HLH-2004 protocol. However, bone-marrow examination in newly diagnosed Moreover, bone-marrow rechec the patients. patients is suggested for the diagnosis and differential diagnosis of HPS. k is helpful for guiding the treatment and evaluating the condition of
出处 《中国小儿血液与肿瘤杂志》 CAS 2013年第3期132-134,共3页 Journal of China Pediatric Blood and Cancer
关键词 噬血细胞淋巴组织细胞增生症 噬血细胞 骨髓 Hemophagocytic syndrome Hemophagocytic Lymphohistiocytosis Hemophagocytosis bone marrow
  • 相关文献

参考文献3

二级参考文献28

  • 1Sullivan KE, Delaat CA, Douglas SD, Filipovich AH. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first-degree relatives. Pediatr Res 1998; 44: 465-468. 被引量:1
  • 2Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991 ; 78:2918 -2922. 被引量:1
  • 3Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr 1991; 80: 428-435. 被引量:1
  • 4Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435-444. 被引量:1
  • 5Sullivan JL, Woda BA, Herrod HG, Koh G Rivara FP, Mulder C. Epstein-Barr virus associated hemophagocytic syndrome: virological and immunopathological studies. Blood 1985; 65: 1097-1104. 被引量:1
  • 6Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistio- cytosis. Crit Rev Oncol Hemat 2002; 44: 259-272. 被引量:1
  • 7Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1987; 111: 530-535. 被引量:1
  • 8Ross CW, Schnitzer B, Weston BW, Hanson CA. Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1991; 115: 470-474. 被引量:1
  • 9Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus associated peripheral T cell lymphoma. Cancer 1993; 72: 909-916. 被引量:1
  • 10Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistio- cytosis. J Clin Oncol 2001; 19: 2665-2673. 被引量:1

共引文献59

同被引文献41

  • 1郭霞,李强,周晨燕.儿童噬血细胞综合征41例临床分析[J].中华血液学杂志,2007,28(7):449-453. 被引量:27
  • 2Verbsky JW, Grossman WJ. Hemophagocytic lymphohis-tiocytosis: diagnosis, pathophysiology, treatment, and fu-ture perspectives [J]. Ann Med, 2006, 38(1): 20-31. 被引量:1
  • 3Filipevieh AH. Hemophagoeytie lymphohistioeytosis (HLH) and related disorders[M]. Hematology Am Soc Hematol Educ Program, 2009, 1(1): 127-131. 被引量:1
  • 4Mehta RS, Smith RE. Hemophagocytic lymphohistiocytosis (HLH): a review of literature. Med Oneol. 2013 Dee;30(4):740. 被引量:1
  • 5Guandalini M, Butler A, Mandelstam S. Spectrum of imaging appe- arances in Australian children with central nervous system hemophagoeytic lymphohistioeytosis. 被引量:1
  • 6Okamoto M, Yamaguchi H, Isobe Y,Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med. 2009;48(10):775-81. 被引量:1
  • 7Goel S, Polski JM, Imran H. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis [J]. Ann Clin Lab Sci, 2012, 42(1):21-25. 被引量:1
  • 8Nielsen M J, Madsen M, M 11er HJ. The macrophage scavenger receptorCD163: endocytic properties of cytoplasmic tail variants. J Leukoc Bio,1 2006, 79: 1-9. 被引量:1
  • 9RavelliA, Magni-Manzoni S, PistorioA, et a,1 Prelmi inary diagno- stic guidelines formacrophage activation syndrome complicatingsystemic juvenile idiopathic arthritis. J Pediatr, 2005, 146: 598-604. 被引量:1
  • 10Filipovieh A H.Hemophagocytie lymphohistiocy - tosis(HLH) and related disorders[J].Hematologyam Soc Hematol Educ Program, 2009,1 : 17-131. 被引量:1

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部